The present invention relates to a novel formulation for treating neurodegenerative disorders, more particularly the present invention relates to drug loaded polymeric nanomicelle for ocular to brain delivery/ocular administration comprising, a polymeric drug carrier nanomicelle, a drug encapsulated within the pol...

ABSTRACT LINAGLIPTIN NANOSUSPENSION FOR NEURODEGENERATIVE DISORDERS The present invention relates to a pharmaceutical formulation comprising of a nanosuspension of Linagliptin for nose to brain delivery for targeting and treating neurodegenerative disorders like dementia. In a particular, the present invention pro...